The Institute of Medicine of the National Academies reports that the state of cancer clinical trials in the U.S. has reached crisis mode. The study cites a number of factors responsible for this situation, such as too much bureaucracy, wasted funds, and lack of patient enrollment. Do you think that the Institute’s proposed goals of (1) improving the speed and efficiency of the design, launch, and conduct of clinical trials, (2) making optimal use of scientific innovations, (3) achieving better selection, prioritization, support, and completion of clinical trials, and (4) fostering expanded participation of both patients and physicians will effectively address the crisis in cancer clinical trials?

Poll Question:
Do you believe that The Institute of Medicine of the National Academies will effectively address the problems in cancer clinical trials?




Previous articleInvida to Commercialize Three Ipsen Drugs in Asia Pacific Countries
Next articleAstraZeneca to Pay $520M Settlement in Seroquel Lawsuit